The heart’s natural pacemaker, the sinoatrial or SA node, normally starts an electrical impulse in the right atrium. The impulse spreads across the atria, the upper chambers, prompting them to contract and move blood into the ventricles, the lower pumping chambers.

The signal reaches the atrioventricular or AV node, where a brief delay allows the ventricles time to fill. It then travels through the bundle of His, right and left bundle branches and Purkinje fibres, coordinating ventricular contraction. Electrical timing and the muscle’s pumping action are connected; a blocked coronary artery or a damaged valve is a different problem.

If the SA node fires too slowly or pauses, the heart may not beat fast enough. If conduction through the AV node or its pathways is interrupted, signals from the atria may reach the ventricles slowly or not at all. Reduced blood flow during a slow rhythm can contribute to fatigue, dizziness, breathlessness or fainting; symptoms can also have other causes.

An implanted pacemaker has a battery-powered pulse generator and electrodes that sense electrical activity and deliver small impulses when programmed conditions are met. Those impulses stimulate heart muscle to contract. A pacemaker supports the rhythm for which it is programmed; it does not open an artery, replace a valve or treat every cause of fatigue or chest pain.

A permanent pacemaker may be offered for a slow or interrupted heartbeat, including sinus-node dysfunction or some types of heart block. A clinician considers the rhythm seen on testing, its cause, symptoms and the consequences of delay. Some people experience dizziness or blackouts; others discover a rhythm abnormality during assessment for another problem.

Heart block describes difficulty passing the signal between atria and ventricles. First-degree block delays conduction, second-degree block means some signals do not get through, and third-degree or complete block means atrial signals do not conduct to the ventricles. Not every degree needs a pacemaker; the pattern, symptoms and clinical situation matter.

An electrocardiogram, or ECG, records the heart’s electrical activity at the time of the test. Longer heart-rhythm monitoring may capture an intermittent problem that a short ECG misses. Depending on the suspected cause, clinicians may use other tests and review your medicines and health. Ask what rhythm was recorded and whether it matches the timing of your symptoms.

A pacemaker may also be needed after a heart procedure if a significant conduction problem persists, or as part of selected treatment for heart failure using cardiac resynchronisation therapy. The indication, urgency and expected benefit depend on the individual.

The aim of pacing for a slow rhythm is to prevent the heart rate from falling below the programmed level and reduce consequences of that rhythm. Symptoms caused by another illness may continue. Ask which symptoms the team expects to improve, what evidence connects them to your rhythm, and what may happen without treatment.

Some conduction problems have a reversible cause, including medicines or an underlying condition, so the team may investigate and address that cause. Some less serious rhythm findings need observation rather than an implant. When a slow rhythm is dangerous or causing significant symptoms, temporary pacing can support the heart while a cause is addressed or a permanent device is arranged. These choices are not interchangeable for every type of block.

A temporary pacing wire is used for short-term support and is different from a permanent implanted system. If observation or a change in treatment is proposed, ask what will be monitored, when the decision will be reviewed, how quickly to seek help for new symptoms and whether there is a risk in waiting. Do not adjust prescribed medicines without the clinician’s instructions.

Consent should include an explanation of expected benefits, important risks and reasonable alternatives, including their consequences. Ask how urgently you need to decide, whether another pacing approach is suitable, and for an interpreter or accessible information if needed. You can ask questions and change your mind before treatment; emergency circumstances can affect the time available.

A conventional transvenous pacemaker usually sits under the skin below the collarbone. One or more insulated wires, called leads, pass through a vein to the heart. A single-chamber system paces one chamber; a dual-chamber system can sense and pace the atrium and ventricle. The choice depends on which part of the electrical pathway needs support and the person’s rhythm.

A leadless pacemaker is a small self-contained device placed inside the heart through a catheter, usually via a vein in the groin. It avoids a chest pocket and a conventional transvenous lead, but has its own access and heart-related risks and is not suitable for every rhythm or person. Capabilities differ by model, so ask exactly what the proposed device can sense, pace and communicate.

Cardiac resynchronisation therapy, or CRT, is pacing intended to improve the timing of the ventricles in selected people with heart failure and electrical delay. CRT-P provides resynchronisation pacing. CRT-D adds defibrillation capability. NICE recommendations depend on factors including symptoms, heart function and the ECG; CRT is not a routine replacement for a standard pacemaker in everyone with a slow pulse.

A pacemaker and an implantable cardioverter defibrillator, or ICD, are different devices. A pacemaker gives low-energy pacing impulses to support rhythm; an ICD can recognise certain dangerous fast ventricular rhythms and treat them with pacing and, when needed, a shock. Some ICDs also have pacemaker functions. An ordinary pacemaker should not be assumed to deliver a defibrillation shock.

Ask whether the planned device is single-chamber, dual-chamber, leadless, CRT-P or CRT-D, and why. Check where it will sit, how it is powered, whether it can respond to activity, and what follow-up is required. Device availability, anatomy, infection risk, rhythm and other heart conditions can affect the choice.

The team will review your history, rhythm tests, previous operations, allergies and current health. Bring an up-to-date list of prescribed and non-prescribed medicines, vitamins and supplements. Tell them about a fever, skin infection, a possible pregnancy or any change in symptoms before the procedure.

Discuss blood thinners and other medicines with the implant team. Their instructions may differ according to the medicine and your risk of bleeding or clotting. Do not stop, start or change anticoagulants or other prescribed drugs independently. Follow your hospital’s own instructions about eating, drinking and medicines on the day.

Ask whether the plan is local anaesthetic with sedation or another anaesthetic, how long you may stay, and who will take you home. Arrange any help you need at home. Tell the team about concerns with lying flat, a previous anaesthetic, accessibility, caring duties or communication needs.

Before giving consent, ask which side and approach are planned, what infection-prevention steps are used, what will happen if the preferred lead position is difficult, and who will explain the result. A planned implant and an urgent implant may follow different timetables.

For a typical chest implant, the skin is cleaned and numbed with local anaesthetic, often with sedation to help you relax. The team monitors your heart and other observations. A small incision is made, usually below the collarbone, and the operator creates a pocket for the generator. Tell the team if you are uncomfortable during the procedure.

The operator guides one or more leads through a vein into the heart using X-ray imaging, checks their position and electrical measurements, and connects them to the generator. The device is programmed and tested before the wound is closed and dressed. You may feel pressure or movement even though the area is numbed.

For a leadless device, a catheter passes through a vein in the groin to place the device inside the heart. The team tests it before removing the catheter. The access site needs its own care and observation for bleeding. Not every pacing requirement can be met by every leadless system.

After a conventional implant the team checks the wound and device, and a chest X-ray may be used to look at the leads and lungs. Many people stay overnight; discharge timing depends on the device, how you feel and any complications. Before leaving, ask for the implant details, wound instructions, activity advice and a contact number.

Pacing can support a slow heart rhythm and reduce symptoms caused by it. Like any invasive procedure it carries risks. These include bleeding or a blood collection under the skin, called a haematoma, infection, and pain or bruising at the implant site. Blood-thinning medication and other health factors affect individual risk.

A lead can move out of position or develop a fault, so pacing may not work as intended and another procedure or adjustment may be required. Other complications of chest implantation include a collapsed lung, damage to a blood vessel or heart, and bleeding around the heart. Abnormal rhythms and very serious complications, including death, can occur. Ask the team which risks matter most for your own procedure.

Leadless implantation has a different access route and risk profile. Problems can include bleeding or injury at the groin vein, injury to the heart and device displacement. Avoiding a chest pocket or a transvenous lead does not remove all procedure risks. Ask how your anatomy and other conditions affect the comparison.

A device infection may involve the pocket or the leads and can be serious. It may require hospital treatment, antibiotics and removal of infected device components. Fever or increasing wound redness, swelling, pain or discharge needs prompt advice. Do not wait for a routine device check to report possible infection.

The risk of treatment should be weighed against the risk of the untreated rhythm. Published figures depend on the procedure and the people studied. Ask your team to explain the risks for your own device, medicines and health, and what they would do if a lead moves or infection develops.

In the MOST randomised trial, 2,010 people with sinus-node dysfunction received either dual-chamber or ventricular pacing, with a median follow-up of 33.1 months. The combined outcome of death or nonfatal stroke was not significantly different between groups. Dual-chamber pacing was associated with a lower risk of atrial fibrillation and a small quality-of-life improvement in that trial.

MOST compared two pacing modes in selected patients who received pacemakers; it did not compare a pacemaker with no treatment or establish the benefit of pacing for every slow rhythm. Devices and programming have evolved, and an average trial result cannot predict an individual response. NICE recommends dual-chamber pacing as an option for symptomatic sick sinus syndrome without AV block; the indication and choice still need individual assessment.

Some soreness and bruising around a chest implant are common initially. Keep the dressing and wound as instructed, take pain relief advised by the team and ask when you may wash. Increasing pain, spreading redness, discharge, fever or significant swelling calls for advice rather than waiting for the scheduled review.

Follow the implant team’s specific advice about moving the arm on the implant side and avoiding heavy lifting or strenuous exercise while the wound and leads settle. Gentle movement and a gradual return to activity are generally encouraged; restrictions and timing depend on the system and individual procedure. Ask for practical guidance for dressing, sleeping, work, lifting, sport and caring responsibilities.

If your implant was leadless, follow the separate instructions for the groin access site and activity. Ask what to do if there is swelling, bleeding or increasing pain and when you can return to work and exercise. Your recovery plan should match the procedure actually performed.

In Great Britain, DVLA guidance says drivers must notify DVLA after pacemaker implantation. Group 1 car and motorcycle drivers must stop driving for at least one week; Group 2 bus and lorry drivers must stop for at least six weeks. Returning is subject to the guidance’s conditions, including satisfactory device function and follow-up, and other diagnoses can change restrictions. Check current rules and your clinician’s advice. Northern Ireland drivers should check the DVA guidance and notification requirements.

Carry your pacemaker identification card and tell healthcare professionals, dentists and emergency staff about your device. The card identifies the system and the clinic that follows it. Keep contact details available when travelling, and ask how to replace a lost card.

Most everyday household electrical equipment can be used normally if it is in good working order. Strong magnets and some electrical or industrial equipment can interfere with a pacemaker. Do not place a mobile phone or magnetic device directly over the implant; follow the device manufacturer’s and clinic’s separation advice. If you feel dizzy near equipment, move away and contact your clinic if symptoms persist.

Before MRI, surgery, radiotherapy or another procedure, tell the team about the device. Some pacemaker systems can undergo MRI under specific conditions, but compatibility depends on the complete system and the scan arrangements. Do not assume that a pacemaker is either always safe or always forbidden in MRI; the treating and device teams must check and coordinate the scan.

You can usually travel and return to exercise once your team says it is appropriate. Show your card at airport security and follow staff instructions; avoid lingering close to security equipment. Ask your clinic about your destination, follow-up and any activity or equipment specific to your work. Pacemakers do not stop other heart conditions from needing care.

Regular checks assess battery life, lead measurements, the device’s stored information and its settings. A cardiac physiologist or device specialist can adjust programming when needed. Follow-up schedules differ by device and circumstances; ask when the first check will happen, whether it is in person or remote, and who to contact between checks.

Some devices transmit information remotely through a bedside monitor or compatible system. The clinic can use these transmissions to review device information and certain alerts, but messages are not necessarily reviewed immediately. Remote monitoring is not an emergency service. Keep the equipment connected as instructed, respond to clinic requests and use urgent or emergency care when symptoms require it.

The battery is sealed within the generator. When it approaches the replacement point, planned generator replacement is usually needed; the existing leads may be kept if they work well. Lead problems or infection can make the plan more complex. Ask how much battery life remains, how replacement is arranged and what the procedure involves for your system.

A leadless device has no chest generator to change in the usual way. When its battery becomes depleted, the team will discuss the options appropriate to the device and your circumstances. Keep attending checks even if you feel well, and report new fainting, dizziness, palpitations or breathlessness rather than relying on the next scheduled appointment.